Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Glen Rock, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
RespireRx Pharmaceuticals Inc. has filed 926 SEC EDGAR filings since 30 Oct 1995

SEC filing history

Showing 26-50 of 208 matching filings.

Per page
25
Current page
2
8-K File 001-16467

8-K filing

Filing date
30 Jul 2021
Reporting date
27 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16467

8-K filing

Filing date
06 Jul 2021
Reporting date
29 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16467

8-K filing

Filing date
14 May 2021
Reporting date
10 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16467

8-K filing

Filing date
06 May 2021
Reporting date
06 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16467

8-K filing

Filing date
03 May 2021
Reporting date
30 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .